For the Inventor, By the Inventor

Enter assignee name

Leiden, Netherlands

Introgene B.v.

USPTO Granted Patents = 18

Trademarks = 1

Forward Citations = 706

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Domenico Valerio (12 out of 21 patents)

Abraham Bout (8 out of 55 patents)

Robert Cornelis Hoeben (6 out of 13 patents)

4. Alex Jan Van Der Eb (4 out of 12 patents)

5. Frits Jacobus Fallaux (4 out of 10 patents)

6. Govert Johan Schouten (3 out of 17 patents)

7. Victor Willem Van Beusechem (3 out of 5 patents)

8. Markus Peter Wilhelmus Einerhand (2 out of 2 patents)

9. Ronald Vogels (1 out of 50 patents)

10. Carl Gustav Figdor (1 out of 15 patents)

11. Stefan Frederik Franciscus Verlinden (1 out of 2 patents)

12. Helmuth Van Es (1 out of 3 patents)

13. Gosse Jan Adema (1 out of 1 patent)

14. Menzo Jans Emco Havenga (1 out of 1 patent)

15. Markus Peter Einerhand (1 out of 2 patents)

18 patents: Sort by Forward Citations

1. 6878549 - Packaging systems for human recombinant adenovirus to be used in gene therapy (2005-04-12),

2. 6602706 - Packaging systems for human recombinant adenovirus to be used in gene therapy (2003-08-05),

3. 6500919 - Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma (2002-12-31),

4. 6498027 - Targeted delivery through a cationic amino acid transporter (2002-12-24),

5. 6472212 - Methods and compositions for genetically modifying primate bone marrow cells (2002-10-29),

6. 6447768 - Methods of gene therapy with a DNA sequence encoding NOS (2002-09-10),

7. 6395519 - Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer (2002-05-28),

8. 6312957 - Genetic modification of primate hemopoietic repopulating stem cells (2001-11-06),

9. 6265212 - Packaging systems for human recombinant adenovirus to be used in gene therapy (2001-07-24),

10. 6261554 - Compositions for targeted gene delivery (2001-07-17),

11. 6238893 - Method for intracellular DNA amplification (2001-05-29),

12. 6232105 - Conditional replication and expression system (2001-05-15),

13. 6204052 - Adenoviral vectors with reduced TNF response and partial E3 region deletion (2001-03-20),

14. 6140103 - Regulated protein expression in stably transfected mammalian cells (2000-10-31),

15. 6051430 - Vectors and methods for providing cells with additional nucleic acid (2000-04-18),

Introgene B.v. is a biotechnology company specializing in the development and production of innovative solutions for gene therapy. With a focus on advancing healthcare through genetic research, Introgene B.v. offers a range of products and services designed to address the growing needs of the biotech industry. Their team of experts is dedicated to providing cutting-edge technologies and ensuring the highest quality standards in all their products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

18 Patents

#11 in Leiden

#389 in Netherlands

#33,165 in the World

Leiden, Netherlands

Introgene B.v.

Forward Citations = 706

21 inventors:

Domenico Valerio (12 out of 21 patents)

Abraham Bout (8 out of 55 patents)

Robert Cornelis Hoeben (6 out of 13 patents)

4. Alex Jan Van Der Eb (4 out of 12 patents)

5. Frits Jacobus Fallaux (4 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…